Overview

A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

Status:
Completed
Trial end date:
2021-10-12
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of a levonorgestrel-releasing intrauterine system (LNG20) in nulliparous and parous females of child-bearing potential who request long-term, reversible contraception for up to 10 years.
Phase:
Phase 3
Details
Lead Sponsor:
Medicines360
Treatments:
Levonorgestrel